Shoulder injuries
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals with shoulder pain in the proximal anterolateral aspect of the shoulder; aggravated by movement; who present symptoms lasting at least three months and who present a minimum score of 50 points on the disability scale (Shoulder Pain and Disability Index)
Exclusion criteria
Exclusion criteria: Individuals with a history of trauma or surgery in the shoulder; total rupture of the rotator cuff and biceps tendon; practitioners of sports-level physical activity involving the upper limbs; individuals with a history of cancer; neurological; cardiac and systemic disorders (rheumatoid arthritis or fibromyalgia) in order not to compromise the study objectives; reproduction of shoulder pain with radiating pain; numbness or tingling in the upper limb as an indication of primary involvement in the cervical or thoracic region; presence of wrist dysfunctions (eg. carpal tunnel syndrome); have undergone physical therapy treatment for the shoulder or any other musculoskeletal condition in the last six months; individuals who have contraindications for physical activity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary 1: Assess the difference between groups for the function outcome at baseline, four and eight weeks after randomization using the Brazilian version of the Shoulder Pain and Disability Index questionnaire;Primary 2: Assess the difference between groups for the pain outcome at baseline, four and eight weeks after randomization by numerical pain scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary 1: Assess the difference between the groups for the function outcome in the six and twelve month assessments after the randomization using the Brazilian version of the Shoulder Pain and Disability Index questionnaire;Secondary 2: Evaluate the difference between groups for the pain outcome at six and twelve months after the randomization by the numerical pain scale;Secondary 3: Assess the difference between groups for the avoidance outcome at baseline, four and eight weeks and six and twelve months after randomization by the Avoidance Daily Activities Photo Scale;Secondary 4: Assess the difference between groups for the self-efficacy outcome at baseline, four and eight weeks and six and twelve months after randomization by the Chronic Pain Self-efficacy Scale;Secondary 5: Evaluate the difference between groups for the kinesiophobia outcome at baseline, four and eight weeks and six and twelve months after randomization by the Tampa Kinesiophobia Scale;Secondary 6: Assess the difference between groups for the catastrophizing outcome at baseline, four and eight weeks, and six and twelve months after randomization by the Pain Catastrophizing Scale (BP-PCS);Secondary 7: Assess the difference between groups for the outcome expectation of improvement at baseline, four and eight weeks, and six and twelve months after randomization using the 5-point Likert scale;Secondary 8: Assess the difference between groups for the health-related quality of life outcome at baseline, four and eight weeks, and six and twelve months after randomization using the 12 Item Short-form Health Survey (SF-12) questionnaire;Secondary 9: Assess the difference between groups for the quality of life outcome at baseline, four and eight weeks and six and twelve months after randomization using the Euroqol 5 and 3 dimensions questionnaire (EQ-5D-3L);Secondary 10: Assess the difference between groups for the central sensitization outcome at baseline, four and eight weeks, and six and twelve mon | — |
Countries
Brazil
Contacts
Faculdade de Medicina de Ribeirão Preto - USP